{"id":"https://openalex.org/W173003252","doi":null,"title":"Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.","display_name":"Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.","publication_year":1993,"publication_date":"1993-06-01","ids":{"openalex":"https://openalex.org/W173003252","mag":"173003252","pmid":"https://pubmed.ncbi.nlm.nih.gov/8348392"},"language":"en","primary_location":{"id":"pmid:8348392","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8348392","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Canadian journal of cardiology","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113705331","display_name":"Jiri Frohlich","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Frohlich","raw_affiliation_strings":["Lipid Clinic, University Hospital, Vancouver, British Columbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lipid Clinic, University Hospital, Vancouver, British Columbia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109984945","display_name":"Louis\u2010Daniel Brun","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L D Brun","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028341176","display_name":"David W. Blank","orcid":"https://orcid.org/0000-0001-6360-7457","observed_orcids":["https://orcid.org/0000-0001-6360-7457"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Blank","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109927016","display_name":"LUCIEN A. CAMPEAU","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Campeau","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109895722","display_name":"Peter M. Crockford","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Crockford","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036567618","display_name":"Gregory P Curnew","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Curnew","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062533506","display_name":"William A. Dafoe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W Dafoe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070770963","display_name":"Jean Davignon","orcid":"https://orcid.org/0000-0002-8365-6552","observed_orcids":["https://orcid.org/0000-0002-8365-6552"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Davignon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061986575","display_name":"Robert Dufour","orcid":"https://orcid.org/0000-0002-2184-4785","observed_orcids":["https://orcid.org/0000-0002-2184-4785"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Dufour","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5082502608","display_name":"Gladys Emery","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Emery","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9374,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.75128284,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"9","issue":"5","first_page":"405","last_page":"12"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lovastatin","display_name":"lovastatin","score":0.9490000009536743},{"id":"https://openalex.org/keywords/simvastatin","display_name":"simvastatin","score":1.0},{"id":"https://openalex.org/keywords/primary-hypercholesterolemia","display_name":"primary hypercholesterolemia","score":0.9700000286102295},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.6980000138282776},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.7129999995231628},{"id":"https://openalex.org/keywords/triglyceride-lowering","display_name":"triglyceride lowering","score":0.7269999980926514},{"id":"https://openalex.org/keywords/apolipoprotein-b","display_name":"apolipoprotein B","score":0.8989999890327454},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.878000020980835},{"id":"https://openalex.org/keywords/apolipoprotein-a-i","display_name":"apolipoprotein A-I","score":0.9259999990463257},{"id":"https://openalex.org/keywords/total-cholesterol-hdl-ratio","display_name":"TC/HDL-C ratio","score":0.7490000128746033},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.6740000247955322},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.6430000066757202},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.3919999897480011},{"id":"https://openalex.org/keywords/short-term-efficacy","display_name":"short-term efficacy","score":0.5199999809265137},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.574999988079071},{"id":"https://openalex.org/keywords/statin-efficacy","display_name":"statin efficacy","score":0.328000009059906}],"concepts":[{"id":"https://openalex.org/C2780940807","wikidata":"https://www.wikidata.org/wiki/Q417740","display_name":"Lovastatin","level":3,"score":0.9834837317466736},{"id":"https://openalex.org/C2776329913","wikidata":"https://www.wikidata.org/wiki/Q670131","display_name":"Simvastatin","level":2,"score":0.9731638431549072},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8407132625579834},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6666883826255798},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.5636934638023376},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5475566983222961},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.509114682674408},{"id":"https://openalex.org/C2779519902","wikidata":"https://www.wikidata.org/wiki/Q1240093","display_name":"Pravastatin","level":3,"score":0.5066245198249817},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5017561912536621},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.4898979067802429},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.46789705753326416},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.42466360330581665},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4060714542865753},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33874714374542236},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.19186091423034668},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.04812583327293396},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008148","descriptor_name":"Lovastatin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008148","descriptor_name":"Lovastatin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D008148","descriptor_name":"Lovastatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019821","descriptor_name":"Simvastatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:8348392","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8348392","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Canadian journal of cardiology","raw_type":"Clinical Trial"},{"id":"mag:173003252","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8348392","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2477754804","https://openalex.org/W847116411","https://openalex.org/W1998872880","https://openalex.org/W2004746082","https://openalex.org/W7056325857","https://openalex.org/W4251604128","https://openalex.org/W81234691","https://openalex.org/W2343897549","https://openalex.org/W1971550142","https://openalex.org/W2419183198"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"compare":[2],"the":[3,47,72,113,150,191,226,376,382,397,403,411,417,453],"safety":[4],"and":[5,9,37,59,85,88,106,159,166,171,184,193,204,212,221,225,239,246,253,257,262,293,302,310,318,331,343,347,352,368,379,400,406,414,429,436,450],"efficacy":[6,151],"of":[7,71,101,129,455],"lovastatin":[8,102,132,158,170,183,192,203,211,220,238,252,261,292,301,309,317,330,342,351,377,398,412,428,449],"simvastatin":[10,104,162,174,185,194,383,404,418,430,451],"in":[11,21,46,75,90,163,175,189,202,206,210,214,219,223,237,244,251,255,260,264,270,285,291,295,300,304,308,312,316,320,329,336,341,345,350,354,360,372,375,381,396,402,410,416,423,439,452],"patients":[12,73,374,395,409],"with":[13,27,157,161,266,356],"primary":[14,459],"hypercholesterolemia.":[15,460],"METHODS:":[16],"Fourteen":[17],"Canadian":[18],"centres":[19],"participated":[20],"this":[22],"double-blind,":[23],"randomized,":[24],"parallel-design":[25],"study":[26,48],"a":[28,32,127],"six-week":[29],"screening":[30],"period,":[31],"four-week":[33],"placebo":[34,86],"baseline":[35,84,143],"period":[36],"an":[38],"18-week":[39],"active":[40],"treatment":[41,454],"period.":[42],"Patients":[43],"were":[44,63,74,147,155,168,283,370,391,431,444],"included":[45],"if":[49,112],"their":[50],"total":[51,60],"cholesterol":[52,115,200,231,249,277,298,323,339],"(TC)":[53],"was":[54,110,116,421],"at":[55,68,83],"least":[56],"6.2":[57,79],"mmol/L":[58,65,82,120],"triglycerides":[61],"(TG)":[62],"4.0":[64],"or":[66,103,133,457],"less":[67],"baseline.":[69],"Half":[70],"stratum":[76,91,164,176,180,286],"I":[77],"(TC":[78,93],"to":[80,126,235,242,327,334,433],"7.8":[81,96],"period)":[87],"half":[89],"II":[92,287],"greater":[94,117],"than":[95,118],"mmol/L).":[97],"The":[98,385],"initial":[99],"dose":[100],"(20":[105],"10":[107],"mg/day,":[108],"respectively)":[109],"doubled":[111],"patient's":[114],"5.2":[119],"after":[121],"six":[122],"and/or":[123],"12":[124],"weeks,":[125],"maximum":[128],"80":[130],"mg/day":[131,135],"40":[134],"simvastatin.":[136],"Of":[137],"298":[138],"randomized":[139],"patients,":[140],"two":[141],"had":[142],"data":[144],"only":[145],"(and":[146],"excluded":[148],"from":[149,240,332],"analysis),":[152],"while":[153],"77":[154],"treated":[156],"74":[160],"I,":[165,181],"72":[167],"on":[169,173],"75":[172],"II.":[177],"RESULTS:":[178],"In":[179],"both":[182,190],"lowered":[186],"TC":[187,289],"(-26.0%":[188],"groups),":[195],"low":[196],"density":[197,228],"lipoprotein":[198,229],"(LDL)":[199],"(-33.4%":[201],"-34.4%":[205],"simvastatin),":[207,215,245,296,305,313,321,337,355],"TG":[208,306],"(-11.4%":[209],"-16.2%":[213],"apolipoprotein":[216],"(apo)-B":[217],"(-24.8%":[218],"-26.3%":[222],"simvastatin)":[224,256,265,346],"TC:high":[227],"(HDL)":[230],"ratio":[232,324],"(from":[233,325],"6.65":[234],"4.73":[236],"6.45":[241],"4.46":[243],"increased":[247],"HDL":[248,276,338],"(+3.6%":[250],"+7.8%":[254],"apo-A1":[258,348],"(+6.3%":[259],"+9.0%":[263],"P":[267,357],"<":[268,279,358],"0.001":[269,359],"all":[271,361],"within-group":[272,362],"tests":[273],"except":[274],"for":[275,288],"(P":[278],"0.05).":[280],"Similar":[281],"results":[282],"obtained":[284],"(-30.7%":[290],"-30.3%":[294],"LDL":[297],"(-37.6%":[299],"-36.8%":[303],"(-21.9%":[307],"-16.9%":[311],"apo-B":[314],"(-32.0%":[315],"-31.7%":[319],"TC:HDL":[322],"8.62":[326],"5.47":[328],"8.96":[333],"5.77":[335],"(+9.7%":[340],"+7.5%":[344],"(+7.2%":[349],"+8.8%":[353],"tests.":[363],"Serious":[364],"adverse":[365,389],"events":[366],"(clinical":[367],"laboratory)":[369],"reported":[371,387],"four":[373],"group":[378,399,413],"three":[380],"group.":[384],"most":[386],"nonserious":[388],"effects":[390],"gastrointestinal":[392],"tract":[393],"(15":[394],"16":[401],"group)":[405],"musculoskeletal":[407],"(14":[408],"11":[415],"group).":[419],"Medication":[420],"withdrawn":[422],"eight":[424],"patients.":[425],"CONCLUSIONS:":[426],"Both":[427],"found":[432],"be":[434],"effective":[435],"well":[437],"tolerated":[438],"each":[440],"stratum.":[441],"However,":[442],"there":[443],"no":[445],"significant":[446],"differences":[447],"between":[448],"moderate":[456],"severe":[458]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}